Trial Profile
A Phase 1 Clinical Study, Randomized, Double-blind, Placebo-controlled, Single-dose, Dose Escalation Study of the Safety and Pharmacokinetic/Pharmacodynamic Profiles of CTB-001 Intravenously Administered in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs CTB 001 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors Chem Tech Research
- 08 Aug 2019 Results of Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis of CTB-001 using data from this trial, published in the Pharmaceutical Research
- 08 Apr 2014 New trial record
- 22 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.